Diretrizes Científicas

🏛️ SUS & Saúde Suplementar 12/12/2018

Incorporação SUS 🩺 Hematologia e Hemoterapia

Eltrombopague olamina — Púrpura trombocitopênica idiopática (PTI)

Fonte: CONITEC (Ministério da Saúde). Tecnologia: Eltrombopague olamina · Indicação: Púrpura trombocitopênica idiopática (PTI) · Recomendação da CONITEC: Incorporar · Decisão do Ministério da Saúde: Incorporar · Portaria SCTIE/MS nº 72/2018 · Relatório técnico Nº 404 · Relatório para a sociedade Nº 93 · Tipo: Medicamento.

Diretrizes & Consensos Médicos

Módulos e Especialidades

Eltrombopague olamina — Púrpura trombocitopênica idiopática (PTI)

Embonato de triptorrelina 22,5 mg administração semestral — Tratamento de puberdade precoce central

Embracing Cultural Diversity in Health Care: Developing Cultural Competence

Emergency and acute medical care in over 16s

Emergency and acute medical care in over 16s: service delivery and organisation

Emicizumabe — Até 12 anos de idade com hemofilia A, moderada ou grave, sem inibidores do Fator VIII

Emicizumabe — Hemofilia A, moderada ou grave, e anticorpos inibidores do Fator VIII, sem restrição de faixa etária.

Emicizumabe — Hemofilia A e inibidores ao fator VIII refratários ao tratamento de imunotolerância

Emicizumabe — Hemofilia A grave ou com nível de atividade de fator VIII inferior a 2%, sem anticorpos inibidores do fator VIII, com até 6 anos de idade no início do tratamento.

Empagliflozina — Adultos com Insuficiência Cardíaca com Fração de Ejeção Preservada e Levemente Reduzida (FEVE > 40%) e classes funcionais NYHA II e III, adicional ao tratamento padrão

Empagliflozina — Diabetes Mellitus tipo 2

Empagliflozina — Diabetes Mellitus tipo 2 e doença cardiovascular estabelecida, com objetivo de prevenção de morte

Empagliflozina — Tratamento da insuficiência cardíaca com fração de ejeção reduzida (ICFEr) e classe funcional NYHA II.

Enabling Aboriginal Health Workers and Non Aboriginal Health Professionals to work collaboratively in the delivery of Health Care to Aboriginal and Torres Strait Islander Australians (Best Practice 18(12))

Encefalite Autoimune (EAI)

Endocrine Therapy for Hormone Receptor–Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline

Endocrine Treatment and Targeted Therapy for HR-Positive, HER2-Negative Metastatic Breast Cancer Guideline and Rapid Update

End of life care for adults

End of life care for adults: service delivery

End of life care for infants, children and young people

End of life care for infants, children and young people with life-limiting conditions: planning and management

Endometriose

Endometriose: Tratamento Cirúrgico

Endometriose em Mulheres com Dor Pélvica Crônica: Tratamento Clínico

Endometriose Intestinal

Endometriosis

Endometriosis: diagnosis and management

Endorsement of the European Association of Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas 11-6v2

Endoscopic Mucosal Resection (EMR) and Endoscopic Mucosal Dissection (EMD) in superficial gastrointestinal tumors

Engaging Clients Who Use Substances

Enhancing the quality of information on colorectal and prostate cancer in the population cancer register of the Basque Country (RCE) and bibliographical review

Enoxaparina — Gestantes com trombofilia

Enoxaparina 60 mg/0,6 mL injetável — Prevenção de tromboembolismo venoso em gestantes com trombofilia

Ensaios enzimáticos em eritrócitos para diagnóstico erros inatos do metabolismo — Doenças Raras

Ensaios enzimáticos em tecido cultivado para diagnóstico de erros inatos do metabolismo — Doenças Raras

Ensaios enzimáticos no plasma, leucócitos e tecidos para erros inatos do metabolismo — Doenças Raras

Enurese: Diagnóstico e Tratamento

Environmental healthcare design strategies and event related anxiety in pediatric patients (Best Practice 16(11))

Enzalutamida — Câncer de próstata resistente à castração metastático virgens de quimioterapia

Enzalutamida — Câncer de próstata sensível à castração e metastático.

Enzalutamida associada à TPA — Câncer de próstata resistente à castração metastático com uso prévio de docetaxel

epic4: Guidelines for the prevention of healthcare-associated infections

EPIDEMIOLOGICAL ANALYSIS OF INFORMATION COLLECTED BY HOSPITAL CANCER REGISTRIES IN THE BASQUE AUTONOMOUS COMMUNITY IDENTIFICATION OF POSSIBLE IMPROVEMENTS WITH REGARD TO THE FEEDBACK AND DISSEMINATION OF RESULTS

Epidermólise Bolhosa (Diretriz Brasileira)

Epilepsia

Epilepsia e trabalho: rastreamento

Epilepsies in children, young people and adults

Epilepsies in children, young people and adults

Epilepsies in children and young people: Investigative procedures and management (SIGN CPG 159)

Eritropoietina — Doença falciforme

ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia

Esclerose Lateral Amiotrófica

Esclerose Múltipla

Esclerose Múltipla

Esclerose Múltipla: Diagnóstico e Tratamento do Surto

Esclerose Múltipla: Diagnóstico por Imagem

Esclerose Sistêmica

ESCMID-ECMM guideline: diagnosis and management of invasive aspergillosis in neonates and children

ESCMID-EUCIC clinical guidelines on decolonization of multidrug-resistant Gram-negative bacteria carriers

ESCMID/EUCIC clinical practice guidelines on perioperative antibiotic prophylaxis in patients colonized by multidrug-resistant Gram-negative bacteria before surgery

ESCMID Clinical Guidelines on the Evaluation and Management of a Reported Antibiotic Allergy

ESCMID COVID-19 guidelines: diagnostic testing for SARS-CoV-2

ESCMID COVID-19 living guidelines: drug treatment and clinical management

ESCMID Generic Competencies in Antimicrobial Prescribing and Stewardship: Towards a European Consensus

ESCMID guideline: diagnosis and treatment of acute bacterial meningitis

ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients

ESCMID guideline for the diagnosis and management of Pneumocystis pneumonia

ESCMID guideline for the diagnosis and treatment of biofilm infections 2014

ESCMID guideline on clinician-targeted interventions to optimise treatment for common acute infections in primary care

ESCMID Guidelines for management of infectious complications after chimeric antigen receptor T cell therapy and bispecific antibodies for haematological malignancies

ESCMID guidelines for management of invasive group A streptococcal infections in adult and paediatric patients

ESCMID guidelines for the diagnosis, clinical management and follow-up of patients with alveolar echinococcosis

ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug‐resistant Gram‐negative bacteria in hospitalized patients

ESCMID guidelines on dosing of antimicrobials in patients with renal impairment with or without RRT

ESCMID guidelines on infection Control Strategies and Interventions to prevent Ventilator-associated Pneumonia in adult patients

ESCMID guidelines on nomenclature, diagnosis and treatment of acute and chronic Q fever

ESCMID guidelines on selection and duration of antibiotic treatment in infectious aortitis and vascular graft and endograft infections

ESCMID guidelines on testing for SARS-CoV-2 in asymptomatic individuals to prevent transmission in the health care setting